Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to Target Solid Tumors & Blood Cancers through Agreement with Califia Pharma

Written By Health Wildcatters
Health Wildcatters
Previous

Axxess Names Home Care Expert Patricia Drea to Senior Leadership Team
Next

Ahead of New Year's Eve, COVID-19 hospitalizations hit record level in Texas